Goodfellow Lynda T, Waugh Jonathan B
Respiratory Care Program, Georgia State University, Atlanta, GA 30302, USA.
Respir Care. 2009 Aug;54(8):1082-90.
Tobacco abuse is one of the main reasons that chronic obstructive pulmonary disease is the fourth leading cause of death in the United States. Many people kick the habit easily, while others struggle through a difficult cycle of addiction. Respiratory therapists often have contact with patients with chronic lung disease who want to quit smoking but do not know where to begin. Smoking bans and clean air laws are in place across the United States, but this is not enough for a complete tobacco treatment and prevention program. For any successful disease-management program, tobacco-control education and support must be included. Studies show that when pharmacologic interventions are used along with the appropriate counseling and other resources, the success of tobacco cessation increases. This must be understood, because if the regulatory efforts of our governing bodies are not enough and if patients do not receive the care that is essential for disease management and rehabilitation, then how will our role as respiratory therapist matter in any health-care system of the future? The respiratory therapist plays a key role in asking patients, especially newly diagnosed patients with chronic lung disease, if they are smokers and if they are interested in tobacco use interventions. This is a role that should not be taken lightly.
烟草滥用是慢性阻塞性肺疾病成为美国第四大死因的主要原因之一。许多人能轻松戒掉这个习惯，而另一些人则在艰难的成瘾循环中挣扎。呼吸治疗师经常接触患有慢性肺病且想戒烟但不知从何开始的患者。美国各地都实施了禁烟和清洁空气法，但这对于一个完整的烟草治疗和预防项目来说还不够。对于任何成功的疾病管理项目，都必须包括烟草控制教育和支持。研究表明，当药物干预与适当的咨询及其他资源一起使用时，戒烟的成功率会提高。必须明白这一点，因为如果我们管理机构的监管努力不够，且患者没有得到疾病管理和康复所必需的护理，那么在未来的任何医疗保健系统中，我们作为呼吸治疗师的角色又有何意义呢？呼吸治疗师在询问患者，尤其是新诊断出患有慢性肺病的患者是否吸烟以及是否对烟草使用干预感兴趣方面起着关键作用。这一角色不应被轻视。
